Effectiveness of bimatoprost (LUMIGAN) as adjunctive therapy with topical beta-blockers in patients with glaucoma or ocular hypertension: A 3-month, multi-center, double-masked, randomized, vehicle-controlled trial with double-masked extension of bimatoprost treatment to 1 year

被引：0
|
作者：
Melamed, S
Bossawska, I
Laroch, C
机构：
[1] Goldschleger Eye Inst, Dept Ophthal, Glaucoma Unit, Tel Hashomer, Israel
[2] Allergan Pharmaceut Inc, Irvine, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1068
引用
收藏
页码：U234 / U234
页数：1
相关论文
共 9 条
  • [1] Bimatoprost/timolol fixed combination: A 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension
    Brandt, James D.
    Cantor, Louis B.
    Katz, L. Jay
    Batoosingh, Amy L.
    Chou, Connie
    Bossowska, Izabella
    JOURNAL OF GLAUCOMA, 2008, 17 (03) : 211 - 216
  • [2] The Safety and Efficacy of Bimatoprost/Timolol Fixed Combination: A 1-year Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension
    Lewis, Richard A.
    Gross, Ronald L.
    Sall, Kenneth N.
    Schiffman, Rhett M.
    Liu, Ching Chi
    Batoosingh, Amy L.
    JOURNAL OF GLAUCOMA, 2010, 19 (06) : 424 - 426
  • [3] Visual field results from a one-year multi-center randomized double-masked study comparing brimonidine tartrate to timolol maleate in the treatment of ocular hypertension and glaucoma
    Choplin, NT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 2332 - 2332
  • [4] The Safety and Efficacy of Bimatoprost/Timolol Fixed Combination: A 1-year Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension (vol 19, pg 424, 2010)
    Lewis, R. A.
    JOURNAL OF GLAUCOMA, 2014, 23 (09) : 663 - 663
  • [5] A Randomized, Multi-Center, Double-Masked, Vehicle-Controlled, Parallel-Group Phase 2b Allergic Conjunctivitis Clinical Trial of Topical Ocular ADX-102, a Novel Aldehyde Sequestering Agent
    Gomes, Paul J.
    Brady, Todd
    Hollander, David
    Clark, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [6] Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled Phase 2b Dry Eye Disease Clinical Trial to Evaluate Safety and Efficacy of Topical Ocular Reproxalap, a Novel RASP Inhibitor
    Sheppard, John D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [7] Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial
    Oddone, Francesco
    Rossetti, Luca
    Tanga, Lucia
    Berardo, Francesca
    Ferrazza, Manuela
    Michelessi, Manuele
    Roberti, Gloria
    Manni, Gianluca
    Centofanti, Marco
    PLOS ONE, 2015, 10 (10):
  • [8] A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea
    Webster, G.
    Draelos, Z. D.
    Graber, E.
    Lee, M. S.
    Dhawan, S.
    Salman, M.
    Magrath, G. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 471 - 479
  • [9] Efficacy and safety of MCO-010 optogenetic therapy for vision restoration in patients with severe vision loss due to retinitis pigmentosa: A phase 2b randomized, sham-controlled, multi-center, multi-dose, double-masked clinical trial (RESTORE)
    Boyer, David
    Bergstrom, Lance
    Emanuelli, Andres
    Gonzalez, Victor
    Wykoff, Charles
    Gupta, Sunil
    Liao, David
    Zak, Vitaliy
    Chavala, Sai
    Mohanty, Samar
    Bataybal, Subrata
    Piltz-Seymour, Jody
    Ayyagari, Ananta
    Koester, John
    Osborne, Aaron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
1